New COVID-19 vaccine candidate provides effective option for low- to mid-income countries
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce […]
The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for […] NEW YORK and MAINZ, GERMANY, October 6, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation […]Candidate
In-licensed candidate may be an effective intervention for preterm infants with respiratory distress syndrome
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2